AU 2015/311866 A1 - Synthetic Genomic Variant-based Secure Transaction Devices, Systems And Methods - The Lens

Synthetic Genomic Variant-based Secure Transaction Devices, Systems And Methods

Published: Mar 9, 2017
Earliest Priority: Sep 03 2014
Family: 14
Cited Works: 0
Cited by: 0
Cites: 0
Additional Info: Full text

Abstract

Various devices, systems, structures and methods are disclosed related to securely authorizing a transaction by synchronizing digital genomic data with associated synthetic genomic variants. An embodiment of the present invention utilizes digital genomic data associated with an entity, such as a person, who may utilize a genome-based security device to complete a transaction. In one embodiment, a person may use a genome-based security device to communicate with an external device over a wireless or other communication interface, synchronize digital genomic data and an associated synthetic variant received from the external device with digital genomic data and associated synthetic variant stored on the genome-based security device.

Claims

A genome-based security device comprising: a memory storing digital genomic data associated with at least one entity, wherein the digital genomic data comprises at least one synthetic variant unique to the at least one entity; a processing unit configurable to execute instructions which upon execution: synchronizes the digital genomic data comprising the at least one synthetic variant with external synthetic variant data received from an external device; and authorizes a transaction upon synchronization of the at least one synthetic variant with respect to the external synthetic variant data; and a communication interface coupled with the processing unit configured to communicatively couple with the external device and operable to receive external synthetic variant data from the external device.
The device of claim 1, wherein the digital genomic data comprises at least a portion of an exome associated with the at least one entity.
The device of claim 2, wherein the at least one synthetic variant is disposed within at least a portion of the exome.
The device of claim 3, wherein the at least one entity comprises a human being.
The device of claim 1, wherein the at least one synthetic variant comprises a single nucleotide polymorphism (SNP).
The device of claim 5, wherein the at least one synthetic variant comprises a set of SNPs. WO 2016/036969 PCT/US2015/048386
The device of claim 1, wherein the at least one synthetic variant is constructed as at least one of the following: an insertion, a deletion, a duplication, a rearrangement, an inversion, a translocation, and a loss of heterozygosity.
The device of claim 1, wherein the at least one synthetic variant comprises at least 100 base pairs.
The device of claim 8, wherein the at least one synthetic variant comprises at least 10,000 base pairs.
The device of claim 9, wherein at least one synthetic variant comprises at least 1,000,000 base pairs.
The device of claim 1, wherein the at least one synthetic variant comprises non contiguous base pairs.
The device of claim 1, wherein the at least one synthetic variant comprises a difference relative to a reference genome.
The device of claim 1, wherein the communication interface comprises a contact pad.
The device of claim 1, wherein the communication interface comprises a wireless interface.
The device of claim 14, wherein the wireless interface comprises a 60GHz chip set.
The device of claim 15, wherein the wireless interface has a communication range of less than 10 cm.
The device of claim 1, wherein the memory comprises a secured portion that stores at least the first synthetic variant. WO 2016/036969 PCT/US2015/048386
A computer program product comprising instructions stored in a non-transitory machine readable medium, the instructions including instructions which when executed by a machine cause the machine to perform: accessing on a memory of the device, a first set of digital genomic data associated with at least one entity, wherein the digital genomic data comprises a first synthetic variant; receiving a second set of digital genomic data is associated with the at least one entity, wherein the second set of digital genomic data comprises a second synthetic variant; and synchronizing the first set of digital genomic data with the second set of digital genomic data, wherein a transaction for the at least one entity is authorized when the first synthetic variant matches the second synthetic variant.
The computer program product of claim 18, wherein the synchronizing the first set of digital genomic data with the second set of digital genomic data comprises generating the first synthetic variant through applying one or more predetermined secret transformation functions to one or more predetermined secret keys and one or more predetermined data selections to create the first synthetic variant.
The computer program product of claim 19, wherein the predetermined secret transformation function is a cryptographic function.
The computer program product of claim 19, wherein the predetermined secret key is a time-based value.
The computer program product of claim 18, wherein the first synthetic variant is received from a remote security server at an initialization time.
The computer program product of claim 18, wherein the synchronizing the first set of digital genomic data with the second set of digital genomic data comprises receiving one or more data packets including the first synthetic variant at a communication interface on a periodic basis. WO 2016/036969 PCT/US2015/048386
The computer program product of claim 23, wherein the communication interface receives data via a secure protocol.
A method of authorizing a transaction using genomic data stored on a device, comprising: accessing on a memory of the device, a first set of digital genomic data associated with at least one entity, wherein the digital genomic data comprises a first synthetic variant; receiving a second set of digital genomic data is associated with the at least one entity, wherein the second set of digital genomic data comprises a second synthetic variant; and synchronizing the first set of digital genomic data with the second set of digital genomic data, wherein a transaction for the at least one entity is authorized when the first synthetic variant matches the second synthetic variant.
The method of claim 25, wherein the first and second synthetic variants encode non genomic data.
The method of claim 26, wherein the non-genomic data comprises at least one of the following: an entity identifier, an account number, a preference, an access level, a permission, a secret token, an image, an audio file clip, a video file clip, a digital object identifier, a healthcare object identifier, and a uniform resource locator.
The method of claim 25, wherein the transaction comprises a healthcare transaction.
The method of claim 25, wherein the transaction comprises a commercial transaction.
The method of claim 25, wherein the transaction comprises a financial transaction.